Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels

MLA

Victor García-Marín, et al. “Non-Survivor Patients with Malignant Middle Cerebral Artery Infarction Showed Persistently High Serum Malondialdehyde Levels.” BMC Neurology, vol. 19, no. 1, Aug. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....52a0ce8e4e9b8aaf3cbbc2bedbffa41b&authtype=sso&custid=ns315887.

APA

Victor García-Marín, Jordi Solé-Violán, Juan J. Cáceres, María M. Martín, Luís F. Ramos, Mónica Argueso, Alejandro Jiménez, Leonardo Lorente, Pedro Abreu-Gonzalez, & Rafael Sabatel. (2019). Non-survivor patients with malignant middle cerebral artery infarction showed persistently high serum malondialdehyde levels. BMC Neurology, 19(1).

Chicago

Victor García-Marín, Jordi Solé-Violán, Juan J. Cáceres, María M. Martín, Luís F. Ramos, Mónica Argueso, Alejandro Jiménez, Leonardo Lorente, Pedro Abreu-Gonzalez, and Rafael Sabatel. 2019. “Non-Survivor Patients with Malignant Middle Cerebral Artery Infarction Showed Persistently High Serum Malondialdehyde Levels.” BMC Neurology 19 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....52a0ce8e4e9b8aaf3cbbc2bedbffa41b&authtype=sso&custid=ns315887.